CBDV Isolate
Cannabidivarin (CBDV) is a rare, non-intoxicating, THC-free cannabinoid from the hemp plant, gaining attention for its unique properties, potential therapeutic benefits and compatibility with a wide range of product applications. Increased interest stems from early research and its potential to support brain, immune and gut health, along with other health benefits.
Key Features of CBDV
- High Purity and Versatility
CBDV isolate is refined to 98% CBDV purity, ensuring a reliable and precisely dosed ingredient for product formulations. Its odorless and flavorless profile has little to no impact on flavor and aroma profiles, offering flexibility across multiple categories. - Non-Intoxicating
With non-detectable levels of THC, THC-Free CBDV Isolate is regulatory compliant, delivering health and wellness benefits without psychoactive effects. - Promising Research: CBDV is one of the most studied minor cannabinoids and has been the subject of research in autism, epilepsy, alopecia, inflammatory bowel disease and pain.
- Global Scalability:
Available in bulk quantities, CBDV caters to both mass-market and niche product development. - Compatibility Across Applications
CBDV seamlessly integrates into various product categories, including:- Tinctures
- Gummies
- Capsules, Soft Gels and Tablets
- Skincare creams, serums and balms
- Pet wellness products
From: $753.00
Need a larger quantity? Contact us for a personalized request for quotation (RFQ) on orders exceeding 20kg.
Delivering What We Promise
Full panel ISO 17025 Accredited Third-Party Lab COAs for added confidence.
- ≥ 98% Pure CBDV
- ≤ 0.01% THC
- Made in the USA
- Appearance – Off-White to Yellow Crystalline Powder
- Fragrance – Little to None
- Taste – As Expected
- Other – Vegan and Non-GMO
ISO 17025-accredited third-party lab COAs ensure the reliability, accuracy, compliance and credibility of our cannabinoid raw materials, while also demonstrating our commitment to safety, quality and consumer trust.
Batch-specific COAs are conveniently accessible via the QR code on the package label or available upon request. To view a COA representative of CBDV Isolate’s full-panel test results, click the “Download COA” button below.
It’s About Trust
THIRD-PARTY TESTING – Each bulk CBDV Isolate batch undergoes testing by an independent ISO 17025-Accredited Third-party Lab. ISO 17025 accreditation ensures that labs are internationally recognized as technically competent and provide reliable, accurate test results, instilling the utmost confidence and trustworthiness. Our batch-specific ISO 17025-Accredited Third-party Lab Certificates of Analysis (COAs) test and verify:
- Precise CBDV Purity and Potency
- Compliant, Non-detectable THC levels
- Absence of Minor Cannabinoids
- Terpene removal
- Federally compliant removal of residual solvents, heavy metals, pesticides and mycotoxins.
Our COAs confirm that our products are 2018 Farm Bill-compliant, meet our rigorous internal quality standards, and comply with current federal & state regulations (read more).
Manufacturing to Specifications
Our cannabinoid raw materials are manufactured to a guaranteed minimum cannabinoid concentration, with product characteristics you can count on for each order. We will gladly supply product specifications upon request.
Request CBDV Isolate Product Specification here.
Wholesale CBDV Isolate Minimum Order Quantities (MOQs)
CBDV Isolate is available in scalable packaging configurations, with MOQs starting at 100g for sampling and R&D. For larger commercial applications (above 20kgs), book a call to discuss wholesale CBDV Isolate bulk-tier pricing and logistics.
Lead Times
We do our best to ship the same day an order is placed, depending on available stock, the time of day the order is received, and the order’s complexity. For bulk CBDV Isolate, our Sales Team can provide you with an estimated lead time based on your order requirements.
Learn More About CBDV Isolate
What is CBDV?
CBDV is a naturally occurring cannabinoid found in cannabis and hemp plants. Structurally similar to cannabidiol (CBD), CBDV is part of the “varin” family (sub-family) of cannabinoids, characterized by a shorter propyl side chain. Unlike THC, CBDV is completely non-psychoactive, making it an attractive option for therapeutic applications without the “high” associated with THC.
What Manufacturing Standards Are Used to Make CBDV?
CBDV is naturally rare and found in extremely small quantities, making large-scale production costly and impractical. However, through advanced research and scientific innovation, our CBDV Isolate is produced under the highest standards to ensure exceptional purity and scalability, offering a more affordable and accessible solution for commercial applications.
Hemp-derived CBDV Isolate is manufactured under tightly controlled manufacturing processes as outlined by stringent food-grade Current Good Manufacturing Practices (cGMP). cGMP compliance is the FDA’s minimum requirements for the methods, facilities and controls used to manufacture, process and pack a drug product to ensure safety and quality with full traceability. Each batch-specific full panel third-party lab COA verifies potency and the compliant removal of contaminants and is available upon request. THC-free CBDV Isolate delivers the highest-purity CBDV at a commercially viable scale.
How Does CBDV Interact with the Body and What Research Has Been Conducted?
CBDV interacts with the endocannabinoid system to influence physiological functions, with scientific literature suggesting that it acts as an agonist of TRPA1, TRPV1 and TRPV2 receptors, an inverse agonist of GPR6, an antagonist of GPR55 and may be an inhibitor of endocannabinoid 2-AG production.
With its unique properties, CBDV has been the subject of recent research and numerous studies, both ongoing and concluded:
- Autism
- Anti-Inflammatory and Inflammatory Bowel Conditions
- Prader-Willi Syndrome (PWS)
- Androgenetic Alopecia
- Nausea
- Skin Conditions (Acne, dry skin)
Contact us so we can assist you in selecting the ideal cannabinoid to help you achieve your formulation objectives.
